control group:Capecitabine

6 trials

Sponsors

Affiliated Cancer Hospital of Harbin Medical University, Hubei Cancer Hospital, Chongqing University Three Gorges Hospital, Shanghai Cancer Center affiliated to Fudan University, West China Hospital, Sichuan University

Conditions

Biliary Tract CancerBreast CancerBreast cancerbreast cancercolorectal cancermammary cancer

Early Phase 1

A single-center, randomized controlled clinical study of nab-paclitaxel combined with capecitabine versus capecitabine monotherapy for paclitaxel/docetaxel resistant advanced breast cancer

RecruitingChiCTR2000039253

Shanghai Cancer Center affiliated to Fudan UniversityBreast cancer

Start: 2020-10-19Updated: 2021-01-25

Phase 2

Capecitabine combined zoledronic acid (CZ) versus capecitabine monotherapy (CAP) for first-line treatment of advanced three negative breast cancer without bone metastasis: a phase II clinical study

Active, not recruitingChiCTR-OIC-17012236

Cancer Hospital Affiliated to Harbin Medical Universitymammary cancer

Start: 2017-09-01Updated: 2017-08-21

Evaluating the Safety and Efficacy of Capecitabine + Finolitimab + Bevacizumab versus Capecitabine as Postoperative Adjuvant Therapy in Biliary Tract Cancer Patients at High Risk of Recurrence:A Randomized, Controlled, Multicenter Phase II Clinical Study

Active, not recruitingChiCTR2500112470

West China Hospital, Sichuan UniversityBiliary Tract Cancer

Start: 2025-12-01Updated: 2025-11-17

Phase 4

To study the therapeutic effect of oral vinorelbine soft capsule combined with capecitabine on HER2 negative advanced breast cancer.

RecruitingChiCTR1900023851

Hubei Cancer Hospitalbreast cancer

Start: 2019-07-01Updated: 2019-06-17

Clinical study on the treatment of second-line and above HER2 negative advanced breast cancer with anrotinib combined with capecitabine

Active, not recruitingChiCTR2000031388

Chongqing University Three Gorges HospitalBreast Cancer

Start: 2020-06-10Updated: 2020-03-30

Unknown Phase

Clinical trial study of Apatinib Mesylate combined with Capecitabine in the treatment of Advanced Colorectal Cancer

Active, not recruitingChiCTR1800014765

Affiliated Cancer Hospital of Harbin Medical Universitycolorectal cancer

Start: 2018-03-01Updated: 2018-02-05